ADVANCED ACCELERATOR APPLICATIONS

Patent Applications and Registrations

Patent applications and USPTO patent grants for ADVANCED ACCELERATOR APPLICATIONS.The latest application filed is for "method of treating cancer by intratumoral deposition of radioactive microparticles".

Company Profile

1.9.10

ADVANCED ACCELERATOR APPLICATIONS - Saint Genis Pouilly FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Neutron activator includes a metallic plate target configured to produce protons through interaction with a proton beam and method of use Grant 11,430,580 - Maciocco , et al. August 30, 2	2022-08-30
Method of Treating Cancer by Intratumoral Deposition of Radioactive Microparticles App 20220265871 - Zahi; Ilyes ; et al.	2022-08-25
Method of Treatment of Neuroendocrine Tumors That Over-Express Somatostatatin Receptors App 20220143227 - Buono; Stefano ; et al.	2022-05-12
Accelerator-driven Neutron Activator For Brachytherapy App 20220148753 - MACIOCCO; Luca ; et al.	2022-05-12
Accelerator-driven neutron activator for brachytherapy Grant 11,257,603 - Maciocco , et al. February 22, 2	2022-02-22
Neutron Activator, Neutron Activation System Comprising Such Neutron Activator And Method For Neutron Activation Implementing Such Neutron Activator App 20210257121 - MACIOCCO; Luca ; et al.	2021-08-19
Accelerator-driven Neutron Activator For Brachytherapy App 20200126683 - MACIOCCO; Luca ; et al.	2020-04-23
Method of Treatment of Neuroendocrine Tumors That Over-Express Somatostatatin Receptors App 20180185524 - BUONO; Stefano ; et al.	2018-07-05
Selective .alpha..sub.v.beta..sub.3 receptor peptide antagonist for therapeutic and diagnostic applications Grant 9,309,288 - Del Gatto , et al. April 12, 2	2016-04-12
New Nucleophile-reactive Sulfonated Compounds For The (radio)labelling Of (bio) Molecules; Precursors And Conjugates Thereof App 20150284326 - Priem; Thomas ; et al.	2015-10-08
Sultone compound derivatives substituted by nucleophiles, in particular radionuclides, and use thereof for marking macromolecules Grant 9,051,292 - Bouteiller June 9, 2	2015-06-09
Use of microrna-199b-5p in medical and diagnostic field Grant 9,017,938 - Zollo April 28, 2	2015-04-28
Selective Alfavbeta3 Receptor Peptide Antagonist For Therapeutic And Diagnostic Applications App 20140094412 - DEL GATTO; Annarita ; et al.	2014-04-03
Selective .alpha.v.beta.3 receptor peptide antagonist for therapeutic and diagnostic applications Grant 8,546,526 - del Gatto , et al. October 1, 2	2013-10-01
Sultone Compound Derivatives Substituted By Nucleophiles, In Particular Radionuclides, And Use Thereof For Marking Macromolecules App 20120220785 - Bouteiller; Cedric	2012-08-30

Company Registrations

NCAGE Code	FB1Z8	ADVANCED ACCELERATOR APPLICATIONS
CAGE Code	FB1Z8	ADVANCED ACCELERATOR APPLICATIONS

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.